Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the D Dimer Testing Market from 2024 to 2025?

The market size of D dimer testing has seen consistent expansion in the past few years. Its growth is projected to increase from $1.47 billion in 2024 to $1.54 billion in 2025, representing a compound annual growth rate (CAGR) of 5.0%. The escalation during the historic period is largely due to the advent of thrombosis research, advancements in lab procedures, clinical validation of d-dimer as a marker, and alteration in diagnostic protocols.

What Is the Projected Market Size of the D Dimer Testing Market?

The market size for D dimer testing is set to experience substantial growth in the coming years, with projections estimating its value at $1.9 billion by 2029, reflecting a compound annual growth rate (CAGR) of 5.4%. Factors contributing to this anticipated growth in the forecast period include a rise in the aging population, advancements in point-of-care testing (POCT), incorporation of risk assessment algorithms, elevated awareness and educational initiatives, as well as regulatory guidance and standardization. The forecast period is also expected to witness significant trends like enhanced diagnosis through the combination of biomarkers, emphasis on swift and precise outcomes, the utility of d-dimer tests in managing COVID-19, the adoption of remote and home-based testing kits, continuous monitoring, and regular testing.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12341&type=smp

Who are the Major Competitors in the D Dimer Testing Market Outlook?

Major companies operating in the D dimer testing market include Kaiser Foundation Health Plan Inc., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson And Company (BD), Laboratory Corporation, Quest Diagnostics Inc., bioMérieux SA, Beckman Coulter Inc., Quidel Corporation, QuidelOrtho Corporation, Sysmex Corporation, Horiba Ltd., Werfen SA, Helena Laboratories Corporation, Abcam plc, LumiraDx Limited, Personalabs, Sekisui Diagnostics LLC, Diagnostica Stago S.A.S., RayBiotech Inc., CTK Biotech Inc., Diazyme Laboratories Inc., AdvaCare Pharma USA, UCP Biosciences Inc., AccuBioTech Co Ltd., Response Biomedical Corporation

What Is Fueling Growth in the D Dimer Testing Market?

The growth of the d-dimer testing market is being accelerated by the rising rates of cancer cases. Cancer, a group of diseases which can occur in nearly any organ or tissue, happens when abnormal cells reproduce uncontrollably, breach normal barriers and spread to or invade neighboring organs. D-dimer testing is primarily used to diagnose, monitor and treat cancer patients, and evaluate the risk of blood clot formation. It also keeps track of thrombotic events in different clinical scenarios. For instance, research from the American Cancer Society, a health organization based in the U.S., forecast in January 2022 that there will be 609,360 cancer deaths and 1.9 million new cancer diagnoses in the U.S. in 2022. This equates to approximately 1,670 deaths every day. As a result, the escalating prevalence of cancer is fueling the expansion of the d-dimer testing market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=12341&type=smp

Which D Dimer Testing Market Segments Are Growing the Fastest?

The D dimer testing market covered in this report is segmented –

1) By Test: Clinical Laboratory Tests, Point-Of-Care Tests

2) By Product: Analyzers, Reagents And Consumables

3) By Method: Enzyme-linked Immunosorbent Assay (ELISA), Latex-enhanced Immuno-turbidimetric Assays, Fluorescence Immunoassays, Other Testing Method

4) By Application: Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Disseminated Intravascular Coagulation (DIC), Other Application

5) By End-User: Hospitals, Academic And Research Institutes, Diagnostic Centers, Other End-User

Subsegments:

1) By Clinical Laboratory Tests: Enzyme-Linked Immunosorbent Assay (Elisa), Chemiluminescent Immunoassay (CLIA), Latex Agglutination Assays, Other Laboratory Testing Methods

2) By Point-Of-Care Tests: Rapid Test Kits, Portable Testing Devices, Lateral Flow Assays, Other Point-Of-Care Testing Methods

Which Industry Trends Are Shaping the Future of the D Dimer Testing Market?

Top firms in the D-dimer testing market are strategically partnering to secure exclusive rights for D-dimer testing solutions, giving them a leg-up in the competition. These strategic partnerships involve companies drawing on each other’s unique capabilities and resources to mutually benefit and succeed. For example, SphingoTec GmbH, a biotech firm based in Germany, joined forces with Rivaara Labs Pvt Ltd., a medical laboratory and healthcare entity from India, in March 2022. With this collaboration, Rivaara acquires sole rights to market and distribute point-of-care tests of SphingoTec that employ groundbreaking biomarkers in the Indian subcontinent. These biomarkers include proenkephalin (penKid) for kidney functionality assessment, bioactive adrenomedullin (bio-ADM) for endothelial function evaluation, and dipeptidyl peptidase 3 (DPP3) as a biomarker for cardiac depression. These groundbreaking markers are complemented by commonly used parameters like procalcitonin, troponin, D-dimer, NT-proBNP, and TSH.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/d-dimer-testing-global-market-report

Which Countries Are Leading the D Dimer Testing Market?

North America was the largest region in the D dimer testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the D dimer testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12341

This Report Delivers Insight On:

1. How big is the d dimer testing market, and how is it changing globally?

2. Who are the major companies in the d dimer testing market, and how are they performing?

3. What are the key opportunities and risks in the d dimer testing market right now?

4. Which products or customer segments are growing the most in the d dimer testing market?

5. What factors are helping or slowing down the growth of the d dimer testing market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model